Prostate Cancer
Detailed information about prostate cancer screening, diagnosis, treatment options, and quality of life considerations.
10 guides · Educational information with linked sources

Prostate Cancer Clinical Trials
Clinical trials offer research-based options for prostate cancer management, though participation requires careful review of protocols, individual risks, and long-term diagnostic implications with your oncologist.

Prostate Cancer Risk Factors and Prevention: Evidence and Limits
Prostate cancer risk factors and prevention strategies require careful consideration. Age, race, and family history are key unmodifiable risks. While lifestyle choices can support general health, no specific diet or supplement is proven to prevent the disease. Screening methods like PSA testing are not diagnostic and carry risks of overdiagnosis, necessitating individualized decisions.

Prostate Cancer Prognosis and Survival Rates: Reading Statistics in Context
Prostate cancer survival rates are group-based averages, not personal predictions. Optimal care requires focusing on individual tumor biology, personal health factors, and informed clinical decision-making.

Prostate Cancer Stages
Understanding prostate cancer staging is key to treatment. This guide explains stages I-IV, grading, and risk factors, aiding informed decisions.

Prostate Cancer Diagnosis
Prostate cancer diagnosis combines screening, imaging, and biopsy. Understanding your test results, like PSA and Gleason scores, is key to individualized care.

Prostate Cancer Symptoms
Prostate cancer symptoms can range from none to urinary changes or bone pain. Recognizing these signs and consulting a doctor is vital, as similar symptoms can arise from non-cancerous conditions.

Urinary and Sexual Changes After Prostate Cancer Treatment
A practical guide to discussing urinary leakage, erection changes, intimacy, and rehabilitation before and after prostate cancer treatment.

Gleason Score and Grade Group: Understanding Prostate Cancer Reports
Learn what Gleason patterns and Grade Groups mean, why 3+4 differs from 4+3, and which other findings matter when discussing prostate cancer care.

Prostate Cancer Treatment: Comparing Surveillance and Active Treatment
Understand why risk, disease extent, overall health, and personal priorities shape the care plan.
PSA Testing: Screening Decisions and Understanding an Elevated Result
Learn what PSA can and cannot tell you, and why screening requires a discussion of benefits and harms.